Browse All

Current Filters

CLEAR FILTER x

TITLE

Solengepras, A Novel GPR6-inhibitor, Shows Potential to Improve Sleep Disturbance in Parkinson’s Disease: Results from the ASCEND Phase Two Trial

Author:Sarva, Harini   Ellenbogen, Aaron   Chou, Kelvin   Isaacson, Stuart   Pahwa, Rajesh   Merchant, Shabbir Hussain   Sheehan, Tim   Diva, Ulysses   Brice, Nicola   Charles, Michelle   Vaidya, Sagar   Xu, Xiao   Dubow, Jordan   Kieburtz, Karl   Hauser, Robert   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.017  

Author Institution:Weill Cornell Medical Center, New York, NY  Quest Research Institute, Farmington Hills, MI  University of Michigan Health, Department of Neurology, Ann Arbor, MI  Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  University of Kansas Medical Center, Kansas City, KS  Beth Israel Deaconess Medical Center, Boston, MA  Beacon Biosignals, MA  U Diva Statistical Consulting, CA  Cerevance, United Kingdom  Clintrex, FL  Parkinson’s Disease and Movement Disorders Center, Department of Neurology, University of South Florida, Tampa, FL